Charles River Laboratories(CRL)

Emerging

Global CRO with $4B revenue supplying 50% of preclinical research models; expanding into gene therapy manufacturing and integrated drug development services.

Updated March 2026

Company Overview

About Charles River Laboratories

Charles River Laboratories International is a global contract research organization (CRO) providing essential services to pharmaceutical, biotechnology, and medical device companies for preclinical drug discovery, development, and safety assessment. Founded in 1947 and headquartered in Wilmington, Massachusetts, Charles River supplies research models (laboratory rodents, primates), preclinical services (toxicology, pharmacology studies), and manufacturing support services including microbial testing and cell and gene therapy development. The company is listed on the NYSE and generates approximately $4 billion in annual revenue.

Business Model & Competitive Advantage

Charles River's research models business — supplying genetically characterized laboratory mice, rats, and other species — is essentially a utility for biomedical research, with the company providing approximately 50% of the preclinical models used in academic and commercial research globally. The company has expanded significantly into biopharmaceutical services, acquiring Argenta (drug metabolism), Absorption Systems, KWS BioTest, and others to provide integrated discovery-to-filing services for small biotech companies and large pharma alike.

Competitive Landscape 2025–2026

In 2025, Charles River navigates a challenging period for contract research organizations. The broader biotech funding contraction of 2022-2024 reduced client spending on early-stage research services, leading to revenue growth deceleration and margin pressure across the CRO sector. The company has undertaken cost reduction measures and portfolio rationalization to align capacity with lower near-term demand. Additionally, activist animal rights pressure on primate research has created regulatory and reputational challenges. Charles River's 2025-2026 strategy focuses on the most profitable service segments — gene therapy manufacturing and regulated safety studies — while managing through the biotech spending normalization cycle.

Revenue
$4000M
Curated content • Fact-checked and verified
Loading News...
Loading Timeline...
Loading Culture...
Loading Leadership...

Open Positions

Reddit Discussions

Loading Competitive Intelligence...

Key Differentiators

Emerging Innovator

Charles River Laboratories is an emerging player bringing innovative solutions to the Technology market.

Enterprise Scale

With $4000M in revenue, Charles River Laboratories operates at enterprise scale with proven market validation.

Frequently Asked Questions

AI Visibility Rankings

How Charles River Laboratories performs in AI search results

AI Rank
?
Track your position
Platforms
5
ChatGPT, Gemini, Claude...
Visibility
?
Your mention rate
Premium Feature

Unlock AI Visibility Tracking for Charles River Laboratories

See exactly how Charles River Laboratories ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.

Real-time Rankings
Track your position daily
Competitive Intel
See how you compare
Platform Breakdown
Per-AI performance
Actionable Insights
Optimize your visibility
Start Tracking for Free

Join 1,000+ brands · Free 7-day trial · No credit card required

Want to improve your AI visibility? Track performance across all major AI platforms.
Compare with Other Brands

Not So Random Others

Adobe Creative Cloud

Enterprise Software
B2bSaasCollaborationGlobalPublic

Adobe Creative Cloud is the flagship subscription product line of Adobe Inc. (NASDAQ: ADBE), encompassing over 20 professional creative applications including Photoshop, Illustrator, InDesign, Premier

Arthur J. Gallagher & Co.

Consumer Finance
B2cFintechInsuranceGlobalPublic

Arthur J. Gallagher & Co. is a Rolling Meadows, Illinois-based global insurance brokerage and risk management company — publicly traded on the New York Stock Exchange (NYSE: AJG) as an S&P 500 Financi

Camden Property Trust

Real Estate & Property Tech
B2bProptechPublicNorth America

Camden Property Trust is a Houston, Texas-based apartment REIT (Real Estate Investment Trust) — publicly traded on the New York Stock Exchange (NYSE: CPT) as an S&P 500 Real Estate component — owning,

Avast

Security
B2bCybersecurityGlobalSaasSecurity

Avast is a Prague-based cybersecurity brand — now part of Gen Digital Inc. (NASDAQ: GEN), formed from the $8.6 billion merger of NortonLifeLock and Avast in 2022 — providing antivirus, internet securi

Best Western

Hospitality
B2cServicesGlobal

Best Western Hotels & Resorts is one of the world's largest hotel chains, operating approximately 4,700 hotels across 100+ countries under a family of brands that spans budget (SureStay), midscale (Be

Nescafé

CPG
B2cManufacturingGlobalFortune500

Nescafé is the world's best-selling coffee brand, owned and operated by Nestlé, the Swiss food and beverage giant. Launched on April 1, 1938, Nescafé was developed at the request of the Brazilian gove

Compare Charles River Laboratories with Competitors

See how Charles River Laboratories stacks up against competitors in Technology with side-by-side revenue, market share, and AI visibility data.

Start Comparison

Track Charles River Laboratories's AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Charles River Laboratories. Get alerts when AI recommendations change. See competitive intelligence across all AI platforms.